Infectious Diseases I
Kalil AC, Patterson TF, Mehta AK, et al. Baricitinib plus
remdesivir for hospitalized adults with Covid-19. N Engl
J Med. 2021;384(9):795-807. https://doi.org/10.1056/
nejmoa2031994
Marconi VC, Ramanan AV, de Bono S, et al. Efficacy
and safety of baricitinib for the treatment of hospi-
talised adults with COVID-19 (COV-BARRIER): a
randomised, double-blind, parallel-group, placebo-
controlled phase 3 trial [published correction appears
org/10.1016/S2213-2600(21)00410-0].
Respir
Med.
2021;9(12):1407-1418.
https://doi.org/10.1016/
S2213-2600(21)00331-3
National Institutes of Health. Coronavirus disease 2019
(COVID-19) treatment guidelines [internet]. National
Institutes of Health (US); 2021 Apr 21–2024 Mar 1.
PMID: 34003615. https://www.ncbi.nlm.nih.gov/books/
NBK570371/pdf/Bookshelf_NBK570371.pdf
RECOVERY Collaborative Group; Horby P, Lim WS,
Emberson JR, et al. Dexamethasone in hospitalized
patients with Covid-19. N Engl J Med. 2021;384(8):693-
704. https://doi.org/10.1056/nejmoa2021436
RECOVERY
Collaborative
Group.
Tocilizumab
in patients admitted to hospital with COVID-19
(RECOVERY): a randomised, controlled, open-label,
https://doi.org/10.1016/s0140-6736(21)00676-0
REMAP-CAP Investigators; Gordon AC, Mouncey
PR, Al-Beidh F, et al. Interleukin-6 receptor antago-
nists in critically ill patients with Covid-19. N Engl J
Med. 2021;384(16):1491-1502. https://doi.org/10.1056/
nejmoa2100433
Rosas IO, Bräu N, Waters M, et al. Tocilizumab in hospi-
talized patients with severe Covid-19 pneumonia. N Engl
J Med. 2021;384(16):1503-1516. https://doi.org/10.1056/
nejmoa2028700
WHO Rapid Evidence Appraisal for COVID-19
Therapies (REACT) Working Group; Sterne JAC,
Murthy S, Diaz JV, et al. Association between adminis-
tration of systemic corticosteroids and mortality among
critically ill patients with COVID-19: a meta-analysis.
jama.2020.17023
WHO Solidarity Trial Consortium. Remdesivir and three
other drugs for hospitalised patients with COVID-19:
final results of the WHO solidarity randomised trial and
1953. https://doi.org/10.1016/s0140-6736(22)00519-0
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ,
Prescott HC. Pathophysiology, transmission, diagnosis,
and treatment of coronavirus disease 2019 (COVID-
org/10.1001/jama.2020.12839